0341 GMT - Raffles Medical Group is likely to benefit from its strategic collaboration with Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Maybank Research's Eric Ong says, noting the recent signing of an agreement. The two entities agreed to establish a "dual circulation" medical resource service system, to advance a new model of collaborative development and promote Shanghai as an international medical tourism hub, the analyst says. Raffles Medical Group's international-standard service system will be integrated into China's domestic healthcare system, the analyst adds. The brokerage raises the stock's target price to S$1.13 from S$1.03, with an unchanged buy rating. Shares are unchanged at S$1.01. (ronnie.harui@wsj.com)
(END) Dow Jones Newswires
April 23, 2025 23:41 ET (03:41 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.